Sign in

CIK 0002020932 · Non-accelerated filer<br>Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
other
Phone
32 3 302 35 30
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
Open-market buys, last 90 days
$592,149
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$592,149. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Epstein David R Director Purchase +5,000 $5.99 $30K 45,000
2026-11-13 Epstein David R Director Purchase +20 $6.00 $120 45,020
2026-11-13 Epstein David R Director Purchase +5,000 $5.75 $29K 50,020
2026-11-13 Epstein David R Director Purchase +4,960 $6.02 $30K 54,980
2026-11-05 Epstein David R Director Purchase +5,000 $6.81 $34K 30,000
2026-11-05 Epstein David R Director Purchase +5,000 $6.91 $35K 35,000
2026-11-05 Epstein David R Director Purchase +5,000 $6.98 $35K 40,000
2026-10-21 Epstein David R Director Purchase +5,000 $8.86 $44K 20,000
2026-10-21 Epstein David R Director Purchase +5,000 $8.90 $45K 25,000
2026-10-08 Epstein David R Director Purchase +5,000 $8.90 $45K 15,000
2026-10-06 Epstein David R Director Purchase +5,000 $8.70 $44K 10,000
2026-10-05 Epstein David R Director Purchase +5,000 $8.57 $43K 5,000

Page 1 of 1 · 12 trades